This antibody selectively stains tumor cell nuclei, avoiding cytoplasmic staining. It targets an epitope located at the C-terminal part of the human progesterone receptor (A/B region). The levels of progesterone and estrogen receptor proteins in breast cancer tissue serve as crucial indicators for prognosis and treatment.